DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

Abbott Laboratories (NYSE: ABT)

44.16 -0.16 (-0.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ABT $44.16 -0.36%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $44.31
Previous Close $44.32
Daily Range $43.97 - $44.38
52-Week Range $35.65 - $44.77
Market Cap $66.5B
P/E Ratio 35.17
Dividend (Yield) $0.88 (2.0%)
Ex-Dividend Date
Dividend Pay Date
10/10/14
11/15/14
Volume 4,651,819
Average Daily Volume 5,093,110
Current FY EPS $2.26

Sector

Healthcare

Industry

Drugs

Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website: http://www.abbott.com/

News & Commentary Rss Feed

5 Things AbbVie Inc.'s Management Wants You to Know

AbbVie knocked the ball out of the park in Q3. Here's what the company's management had to say.

Dividend Aristocrats In Focus Part 45: AbbVie

Dividend Aristocrats In Focus Part 41: Abbott Laboratories

PE-backed Petco Animal Supplies Scoops up Drs. Foster & Smith

Zoetis Provides 2015 Earnings Guidance Below Estimates - Analyst Blog

Zoetis Provides 2015 Earnings Guidance Below Estimates - Analyst Blog

Independent Thinking For Successful Dividend Investing

Zoetis to Buy Abbott's Animal Health Assets for $255 Million - Analyst Blog

The Passive DGI Portfolio: Quarterly Portfolio Update

UPRO, ABT, ACT, ADT: ETF Outflow Alert

Benzinga's M&A Chatter for Monday November 17, 2014

Dividend Aristocrats In Focus Part 41: Abbott Laboratories (ABT)

Dividend Aristocrats In Focus Part 41: Abbott Laboratories (ABT)

See More ABT News...

ABT's Top Competitors

ABT $44.16 (-0.36%)
Current stock: ABT
JNJ $106.70 (-0.17%)
Current stock: JNJ
NVS $95.04 (0.28%)
Current stock: NVS
RHHBY $37.21 (-0.37%)
Current stock: RHHBY